ImmuCell

$5.82
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.23 (+4.10%) Today

-$0.02 (-0.34%) As of 11:00 PM UTC after-hours

Why Robinhood?

You can buy or sell ImmuCell and other stocks, options, and ETFs commission-free!

About ICCC

ImmuCell Corp. engages in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kit and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME. The listed name for ICCC is ImmuCell Corporation Common Stock.

CEO

Michael F. Brigham

Employees

Headquarters

Portland, Maine

Founded

1982

Market Cap

42.12M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

4.95K

High Today

$5.84

Low Today

$5.64

Open Price

$5.65

Volume

2.35K

52 Week High

$8.13

52 Week Low

$3.70

Collections

ICCC Earnings

-$0.11

-$0.06

-$0.02

$0.03

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Estimated

-$0.08 per share

Actual

-$0.04 per share

Replay Earnings Call